It is hard to imagine a world without monoclonal antibodies (mAbs). They are widely used in the scientific community and have assisted in the advancement of research and development.
As reagents and therapeutics in their own right, they have played an important role in the advancement of basic research, diagnostics and product development, and they have delivered huge patient benefits across a wide range of therapeutic areas.
Moreover, technologies such as antibody phage display and humanized mice have expanded the available options to generate novel mAbs, in particular human or humanized mAbs for therapeutic purposes.
This is the third in a series of three white papers reviewing the custom antibody production and the use antibodies in the development of therapeutic products. In this white paper 'Considerations in the production of antibodies as reagents: Monoclonal antibodies'
Absolutely. Just sharing some free knowledge that we hope you’ll find useful. Keep us in mind next time you have any questions!